Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Sitagliptin (Primary) ; Insulin; Insulin aspart; Insulin glargine; Insulin lispro; Metformin/sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Sita-Hospital
- 31 Aug 2018 Biomarkers information updated
- 12 Apr 2016 Status changed from active, no longer recruiting to completed.
- 14 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.